Adrian Vega holds a degree in Pharmacy from the Universidad Complutense of Madrid. He earned his doctorate in Molecular Biosciences in 2021 working at CNB-CSIC (Madrid, Sapin). During his PhD work he studied the innate immune system in the context of bacterial infections. He is currently a postdoctoral researcher at Weill Cornell Medicine (New York, USA) where he uses CRISPR base editing technologies to better understand the immune microenvironment in the context of tumor development.